ArticleBMC digital health2024
From an idea to the marketplace: Identifying and addressing ethical and regulatory considerations across the digital health product-development lifecycle.
Article in BMC digital health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Lean-Agile Product Development in FDA Relevant and Regulated Medical Device Contexts.Therapeutic innovation & regulatory science · 2026Review
- "An App That Truly Works for Us": Co-Designing a Mobile Health Intervention to Support the Transition to Adulthood for the Latino Autism Community.Journal of technology in behavioral science · 2026Article
- Development of an evidence-based evaluation framework for digital health software products.Scientific reports · 2025Article
- TELEHEALTH and digital health platforms in promoting access to sexual reproductive health self care among youth: A case of rocket health services in Uganda.PLOS digital health · 2025Article
- Ethics From the Outset: Incorporating Ethical Considerations into the Artificial Intelligence and Technology Collaboratories for Aging Research Pilot Projects.The journals of gerontology. Series A, Biological sciences and medical sciences · 2025Article
- Progress Achieved, Landmarks, and Future Concerns in Biomedical and Health Informatics.Healthcare (Basel, Switzerland) · 2024Review
- Applying Machine Learning Techniques to Predict Drug-Related Side Effect: A Policy Brief.Inquiry : a journal of medical care organization, provision and financingArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Widespread adoption of digital health tools has the potential to improve health and health care for individuals and their communities, but realizing this potential requires anticipating and addressing numerous ethical and regulatory challenges. Here, we help digital health tool developers identify ethical and regulatory considerations - and opportunities to advance desirable outcomes - by organizing them within a general product-development lifecycle that spans generation of ideas to commercialization of a product.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.